Clinical study using mesenchymal stem cells for the treatment of patients with severe COVID-19

The Coronavirus disease 2019 (COVID-19) caused by SARS-CoV-2 was identified in December 2019. The symptoms include fever, cough, dyspnea, early symptom of sputum, and acute respiratory distress syndrome (ARDS). Mesenchymal stem cell (MSC) therapy is the immediate treatment used for patients with sev...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Front Med
Main Authors: Tang, Lingling, Jiang, Yingan, Zhu, Mengfei, Chen, Lijun, Zhou, Xiaoyang, Zhou, Chenliang, Ye, Peng, Chen, Xiaobei, Wang, Baohong, Xu, Zhenyu, Zhang, Qiang, Xu, Xiaowei, Gao, Hainv, Wu, Xiaojun, Li, Dong, Jiang, Wanli, Qu, Jingjing, Xiang, Charlie, Li, Lanjuan
Formato: Artigo
Idioma:Inglês
Publicado em: Higher Education Press 2020
Assuntos:
Letter to Frontiers of Medicine
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC7406954/
https://ncbi.nlm.nih.gov/pubmed/32761491
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s11684-020-0810-9
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados